Genmab | GEN - Trade Creditors


Genmab reported DKK6M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Almirall EUR 235.53M 22.52M Jun/2026
Amarin USD 18.8M 29.36M Jun/2026
Amgen USD 2.86B 16.65B Jun/2026
argenx SE USD 719M 164.73M Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Bayer EUR 6.59B 496M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Demant DKK 923M 41M Dec/2025
Exelixis USD 24.15M 5.47M Mar/2026
Fresenius Medical Care EUR 890.43M 54.88M Mar/2026
Genmab DKK 6M 2M Sep/2025
GlaxoSmithKline GBP 14.34B 7M Jun/2026
GN Store Nord DKK 1.01B 486M Mar/2026
GRIFOLS EUR 1B 160M Jun/2026
Hikma Pharmaceutical USD 715M 104M Dec/2025
Insmed USD 73.38M 6.53M Mar/2026
Lakefront Biotherapeutics EUR 95.77M 8.88M Mar/2026
Lonza CHF 471M 3M Dec/2024
Merck EUR 2.13B 19M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
UCB EUR 4.04B 755M Dec/2025